Details for Patent: 8,932,610

Which drugs does patent 8,932,610 protect, and when does it expire?

Patent 8,932,610 protects OTOVEL and is included in one NDA.

This patent has eighteen patent family members in fifteen countries.

Summary for Patent: 8,932,610

Title:	Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation
Abstract:	A pharmaceutical otic sterile preservative-free composition in the form of a clear aqueous solution comprising 0.01-0.10% (w/v) of Fluocinolone Acetonide, optionally accompanied by 0.1-0.8% of Ciprofloxacin or a pharmaceutically acceptable salt thereof, a nonionic surfactant, a tonicity adjusting agent and a viscosity increasing agent. It is useful for the prevention and/or treatment of otic inflammation, optionally accompanied by bacterial infection, and for administration from single-use containers.
Inventor(s):	Ruiz I Pol; Jaume (Esplugues de Llobregat, ES), Izquierdo Torres; Francisca (Esplugues de Llobregat, ES)
Assignee:	Laboratorios Salvat, S.A. (Esplugues de Llobregat (Barcelona), ES)
Application Number:	12/730,681
Patent Claim Types: see list of patent claims	Composition; Formulation; Use; Dosage form;

Drugs Protected by US Patent 8,932,610

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Laboratorios Salvat	OTOVEL	ciprofloxacin hydrochloride; fluocinolone acetonide	SOLUTION/DROPS;OTIC	208251-001	Apr 29, 2016		RX	Yes	Yes			Y			TREATMENT OF ACUTE OTITIS MEDIA

Foreign Priority and PCT Information for Patent: 8,932,610

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	10155005	Mar 1, 2010

International Family Members for US Patent 8,932,610

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	080368
Australia	2011223095
Brazil	112012021638
Canada	2790652